Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Lecture on interpretations and translations of San place names
2011-09-23

Prof. Peter Raper, recently appointed as Honorary Professor: Linguistics, in the Department of Language Management and Language Practice at the University of the Free State, will deliver his inaugural lecture on Tuesday evening, 27 September 2011. His topic for the evening is “Interpretations and translations of Bushman (San) place names”. With this inaugural lecture, he also introduces an interesting one-day international colloquium on the theme: “Name-change planning – striving towards authenticity”.A panel discussion about street-name changes in Bloemfontein forms part of this colloquium and promises to elicit a stimulating debate.

Prof. Raper is probably better known for three popular place-name dictionaries, Streekname in Suid-Afrika en Suidwes, published in 1972; the Dictionary of Southern African Place Names, published in 1987, updated in 1989 and published in 2004 with some additions as New dictionary of South African place names; and Hottentot (Khoekhoen) place names, a dictionary compiled in collaboration with the famous Prof. G S  Nienaber (a former Kovsie). In fact, Prof. Raper’s work is a continuation of their world-renowned series, Toponymica Hottentotica, which was published between 1977 and 1981. It is generally regarded as the most authoritative work on Hottentot place names. His current interest in Bushman place names builds on this pioneering work and is actually also a re-evaluation of the underestimated role of the Bushman with regard to place naming in South Africa up to now. His work offers a new perspective on what could be regarded as the “first” or earliest names of places in South Africa and brings a sobering perspective to the current debates regarding place-name changes where various claims are made about “who has given the name first”.

However, Prof. Raper is also known for his role in the standardisation of place names, both nationally and internationally. In South Africa, he has served on the South African National Place Names Committee (1972-1999), the South African Geographical Names Council (1999-2002) and, since 1981, on the Names Society of Southern Africa. Currently, he is an honorary member of this association. Since 1984, he has also been serving on the United Nations Group Experts on Geographical Names and has even been the Chairperson of this Leading international standardisation body (1991-2002).

Apart from this, Prof. Raper regularly publishes his research on geographical names in a variety of academic journals and still participates in the most important national and international conferences on names on a regular basis. Prof. Raper is honoured as South Africa’s foremost names expert.

His inaugural lecture will introduce a colloquium on names planning, presented by his host department. Experts from Lesotho, Zimbabwe and the USA are participating in the proceedings, amongst others, the current Chairperson of the Names Society of Southern Africa, Prof. Adrian Koopman (University of KwaZulu-Natal).

RSVP: Joy Maasdorp on +27(0)51 401 2405 or maasdorpjh@ufs.ac.za before or on Thursday, 22 September 2011.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept